Ureteroenteric Anastomotic Strictures: Treatment with Palmaz Permanent Indwelling Stents

Sanders, Rodney; Bissada, Nabil K.; Bielsky, Stephen

doi:10.1016/s0022-5347(17)35517-9

Cited by 32 publications

(10 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…1 More recently, metal stents have been used in the treatment of UEAS, with reported patency rates approaching 100% with limited follow-up. [2][3][4][5][6][7] However, the lack of long-term follow-up precludes definitive conclusions regarding the durability of metal stent placement. Further, the surgical experience and potential difficulties associated with open surgical repair of UEAS after stent failure are unknown.…”

Section: Introduction U Reteroenteric Anastomotic Stricturementioning

confidence: 99%

Case Report: Urothelial Hyperplasia Causing Recurrent Obstruction after Ureteral Metal Stent Placement in Treatment of Ureteroenteric Anastomotic Stricture

Rapp

Orvieto²,

Lyon³

et al. 2006

Journal of Endourology

View full text Add to dashboard Cite

Initial experience utilizing metal stents in the treatment of ureteroenteric anastomotic strictures has yielded promising results. However, the long-term efficacy of metal stent placement remains unknown. Further, there is a paucity of literature to describe the technical considerations associated with the surgical management of obstruction after metal stent failure. We report the case of a 67-year-old man undergoing bilateral ureteral metal stent removal and ileal conduit creation following stent failure and recurrent obstruction.

show abstract

Section: Introduction U Reteroenteric Anastomotic Stricturementioning

confidence: 99%

Case Report: Urothelial Hyperplasia Causing Recurrent Obstruction after Ureteral Metal Stent Placement in Treatment of Ureteroenteric Anastomotic Stricture

Rapp

Orvieto²,

Lyon³

et al. 2006

Journal of Endourology

View full text Add to dashboard Cite

show abstract

“…[2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] Both balloon dilation and endoureterotomy have been used. [2][3][4][5][6] Although the patency rates following balloon dilation have been reported to be as high as 80% with more than 3-year followup, 2 most other studies have reported much more limited success, with patency rates ranging from 15% to 61% at followup of 12 to 16 months.…”

Section: Introductionmentioning

confidence: 99%

“…[21][22][23] Several small series have investigated the benefit of permanent metal stents in the treatment of ureteroenteric anastomotic strictures. [7][8][9][10][11][12] In view of the favorable success rates seen in previous trials, we set out to investigate the efficacy of metal stent placement for the treatment of ureteroenteric anastomotic strictures in patients who had failed previous balloon dilation or laser endoureterotomy.…”

Section: Introductionmentioning

confidence: 99%

Percutaneous Placement of Permanent Metal Stents for Treatment of Ureteroenteric Anastomotic Strictures

Rapp

Laven²,

Steinberg³

et al. 2004

Journal of Endourology

View full text Add to dashboard Cite

show abstract

“…Die Nachbeobachtungszeit lag zwischen 3 und 90 Monaten (Tabelle 5), [1,4,8,9,11,12,14,15,19,20,21,22]. Die Erfolgsrate aller dieser Behandlungen lag bei 69,3% (68/98).…”

unclassified

“…Es kamen 5 verschiedene Stents zur Anwendung: Wall-Stent, PalmazStent, Strecker-Stent, Memotherm-Stent und Sinus-Stent.Die verwendeten Durchmesser lagen zwischen 4 und 10 mm. 11 von 12 Autoren zogen positive Schlüsse aus ihrer Arbeit [1,4,8,9,11,12,14,15,20,21,22], und nur eine Arbeitsgruppe bezeichnete die Methode als ineffektiv [19], (s. Tabelle …”

unclassified

Selbstexpandierende permanente endoluminale Stents (SPES) zur Therapie der benignen Harnleiterobstruktion 6 Jahre eigene Erfahrung und Literaturübersicht

Pauer¹

2002

Urologe [A]

View full text Add to dashboard Cite

At the urologic department of the Public General Hospital in Wels between 1994 and 2000, a self-expanding permanent endoluminal stent (SPES) was implanted in 13 women and 1 man (mean age: 52.2 years) with ureteral strictures. All patients had previously been treated unsuccessfully. An open operative approach was not possible because of various contraindications or because the patient had refused surgery. During a total follow-up period of 730 months (median: 59.9 months), primary patency lasted 669.3 months (median: 47.8 months). In nine patients no further intervention was necessary, and in four patients patency could be regained by additional interventions. In one patient the kidney had to be removed because of progressive renal insufficiency. Worldwide 98 cases of a SPES implant have been published so far. The patency rate was 68 of 98 stents (69.3%). The implantation of a SPES in the ureter for benign and complicated strictures represents a serviceable alternative to other urinary diversions. Additional clinical and experimental studies and long-term results are needed to make a definitive assessment of this method.

show abstract

Ureteroenteric Anastomotic Strictures: Treatment with Palmaz Permanent Indwelling Stents

Cited by 32 publications

References 12 publications

Case Report: Urothelial Hyperplasia Causing Recurrent Obstruction after Ureteral Metal Stent Placement in Treatment of Ureteroenteric Anastomotic Stricture

Case Report: Urothelial Hyperplasia Causing Recurrent Obstruction after Ureteral Metal Stent Placement in Treatment of Ureteroenteric Anastomotic Stricture

Percutaneous Placement of Permanent Metal Stents for Treatment of Ureteroenteric Anastomotic Strictures

Selbstexpandierende permanente endoluminale Stents (SPES) zur Therapie der benignen Harnleiterobstruktion 6 Jahre eigene Erfahrung und Literaturübersicht

Contact Info

Product

Resources

About